skip to primary navigationskip to content
 

Addenbrooke's takes over the GeneAdviser ordering platform for genetic testing

last modified Jun 21, 2017 03:42 PM
GeneAdviser's platform to live on as in-house NHS tool

ideaSpace alumni, GeneAdviser, a start-up with the aim of making genomic medicine more accessible is handing over its ordering platform for use within the NHS. The Cambridge start up will be closing its doors after the handover.

“Our goal has always been to make genomic medicine more accessible. We are delighted that this transition will mean that doctors will have long term access to the platform for use within the NHS.” said Dr Jelena Aleksic, GeneAdviser’s CEO.

The move follows the decision not to seek further investment for GeneAdviser, despite the platform being fully operational and having more than ten partner laboratories offering tests worldwide. “While as a unique product it is not enough to maintain a company, the platform is perfect as part of the NHS, making sure it remains accessible for doctors to use”, added Dr Aleksic. “This will also ensure the future of the platform independently of GeneAdviser”.

The platform will be maintained by the Cambridge University Hospitals NHS Regional Genetics Centre at Addenbrooke’s hospital. “The long-term goal is to get the platform adopted for genetic test ordering across the NHS,” said laboratory director Dr Steve Abbs. “We believe that the GeneAdviser platform solves an important problem of genetic test access, and we are very pleased that it will become an in-house NHS tool.” 

“It was always important for us to work closely with the genetics community," said Dr Robert Stojnic, GeneAdviser’s CTO. “We believe that being maintained directly by the community is the best move for the future growth and sustainability of the platform." 

The platform will be handed over to Addenbrooke's in late June, and will continue to be available through www.geneadviser.com during the transition period. It will later become a part of the NHS N3 computing network. Accessibility is guaranteed for all users during the transition.

For interviews and more information, contact:

  • Jelena Aleksic, GeneAdviser, jelena@geneadviser.com, +44 (0)7793534121

 

Notes to editors

About GeneAdviser

http://www.geneadviser.com 

Genetics is advancing at a rapid pace, transforming research and revolutionising the way we diagnose and treat complex diseases such as heart disease and cancer. We are a team of scientists and developers specialised in genetics and bioinformatics, working to increase access to genomic medicine in the clinic. 

We have developed an ordering platform to make genomic medicine more accessible, partnering with a portfolio of private and public laboratories in the UK and overseas. Our flexible, powerful online ordering platform for genetic tests enables clinicians to find and order tests for all medical specialities.  

About Cambridge University Hospitals NHS Regional Genetics Centre

http://www.cuh.org.uk/clinical-genetics

Addenbrooke’s is a centre of excellence for medical genetics and rare cancer treatment. The Genetic Testing Laboratory is part of the East Anglian Medical Genetics Service. The genetics laboratories offer cytogenetic (chromosome) and molecular genetic (DNA) analysis.

The laboratories are located within purpose built facilities (built 2007), and are rapidly expanding with more than 60 staff consisting of clinical scientists, biomedical scientists, genetic technologists, healthcare scientist trainees at different levels and administration staff.

 

 

RSS Feed Latest news

LESSONS FROM A FOUNDER: Taking Your Technology to Market with Scott White from PragmatIC

Mar 14, 2019

Scott White, ideaSpace alumni and serial entrepreneur is CEO of PragmatIC. PragmatIC produces sheets of flexible integrated circuits (FlexICs), extending the reach of electronics into markets unfeasible for silicon for reasons of form factor and/or cost. Printed electronics is one of the world’s fastest growing technologies, representing enormous potential in interconnected devices. In recognition of British Science Week, we spoke to Scott about the company’s journey from a technology-based concept to the production of commercial products, and asked his advice about taking a new technology to market.

LESSONS FROM A FOUNDER: Basics of Building a Business - IP with Christian Bunke

Feb 28, 2019

With the next B3 event coming up in the next few weeks, we thought we’d take a look back at some previous B3s and learn more about what it takes to build a business. But first – a bit about B3. Our Basics of Building a Business event, or B3, is hosted by a Founder who has successfully scaled their business. They invite the three people who proved vital in helping them along the way to share what they did, how they did it and so much more on what you need to do to go from start up to scale up. Late last year Adam Durant, CEO of Satavia and alumni of ideaSpace, was our guest founder for the evening and invited along Christian Bunke of Basck - an IP Firm focused on working with startups. Here’s what he had to say…

Spotlight on Mursla

Feb 03, 2019

Cancer is one of the most challenging global issues an entrepreneur could choose to tackle. But Pierre Arsène and Victor Serdio are doing just that with their company Mursla. Based at ideaSpace West, Mursla is developing a breakthrough technology for early cancer detection using liquid biopsies, offering a less invasive and more responsive approach to diagnosis, treatment and cure. To mark World Cancer Day on the 4th February, we asked Pierre to explain more about Mursla and the bold ideas and enthusiasm driving this bright company.

LESSONS FROM A FOUNDER: What's Your 2019 Startup Goal?

Jan 30, 2019

For many of us, a new year often starts with an optimistic resolution to change – join the gym, write a book, travel perhaps. But if you’re running a startup, January is a great time to assess your company’s development and set fresh goals for the coming year. We asked four founders at ideaSpace to reflect on progress and share their area of focus for 2019.

GeoSpock Lands £10 Million in Additional Funding 

Jan 09, 2019

ideaSpace alumni and extreme data specialists, GeoSpock, have secured an extra  £10 million in funding. The latest round was led by Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain and 31Ventures. Japanese data tech company KDDI Supership joined as a strategic investor. Investment was also secured from existing investor, Jonathan Milner.

View all news